• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN SA Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Restricting Drug Samples May Reduce Costs

Restricting Drug Samples May Reduce Costs

September 1, 2009
From The Carlat Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Section editor, Glen Spielmans, PhD

Drug samples are a staple of pharma- ceutical marketing. The drug industry argues, quite logically, that samples are useful to treat patients who lack the funds to purchase medications. Yet some reformers have called for drug samples to be banned, an idea that has received a decidedly mixed reception. A small body of research has investigated the topic of drug samples, including a recent study that examined changes in prescriptions when samples of brand- name statins, levothyroxine, and SSRIs were removed from an internal medicine clinic in Iowa. Over the 180-day period in which samples were removed, generic prescriptions increased by 23% for statins, 10% for SSRIs, and 3% for levothyroxine (Miesner AR et al., Arch Intern Med 2009;169:1241-1242). In another study, a university-based internal medicine clinic moved, leaving its sample closet inaccessible for nine months. During this time, the rate of generic pre- scribing for uninsured patients increased from 12% to 30%, though there was no change in generic prescribing for Medicaid patients (Miller DP et al., South Med J 2008;101:888-893).

Surprisingly, drug samples are more often given to insured Americans than to the uninsured or poor (Cutrona SL et al., Am J Public Health 2008;98:284-289). In that case, drug samples also tend to increase costs for patients who receive them (Alexander GC et al., Med Care; 46:394-402); when patients receive a sample, they often remain on that more expensive drug once the sample expires rather than switching to a less expensive generic drug. Samples probably produce overall cost savings only if they will be given indefinitely to patients who have no coverage for prescriptions and cannot afford to pay out of pocket for generic drugs. 

TCPR’s Take: The combined results of these studies suggest that clinicians should be wary of drug samples and con- sider carefully whether they are actually helping to reduce costs for patients.

General Psychiatry
KEYWORDS practice-tools-and-tips
    www.thecarlatreport.com
    Issue Date: September 1, 2009
    SUBSCRIBE NOW
    Table Of Contents
    Thinking like a Neurologist
    Restricting Drug Samples May Reduce Costs
    N-Acetylcysteine Effective For Trichotillomania
    Treating Headaches in Psychiatry
    Evaluating and Treating Tremor
    Role of Depression “Risk Gene” Questioned
    DOWNLOAD NOW
    Featured Book
    • PB4e_Cover2.png

      Psychiatry Practice Boosters, Fourth Edition (2023)

      Teaches you the key points of 63 of the most clinically relevant studies in psychiatry.
      READ MORE
    Featured Video
    • therapist_canstockphoto9201097.jpg
      General Psychiatry

      Using SAMe In Clinical Practice with Garrett Rossi, MD

      Read More
    Featured Podcast
    • canstockphoto6759394.jpg
      General Psychiatry

      Throwback Thursday: Brief Therapy for ADHD

      You started a stimulant medication for a young woman with ADHD. When she returns her symptoms are 70% better, but what can we do about the rest? Today a conversation with...

      Listen now
    Recommended
    • Approaches to Autism Intervention

      January 31, 2022
      canstockphoto2240982_child-bubbles_thumb.jpg
    • Currently Available Cannabis Products

      September 1, 2022
    • Interpreting Assessment Discrepancies from Multiple Sources

      October 17, 2022
      ChildAssessment.png
    • Approaches to Autism Intervention

      January 31, 2022
      canstockphoto2240982_child-bubbles_thumb.jpg
    • Currently Available Cannabis Products

      September 1, 2022
    • Interpreting Assessment Discrepancies from Multiple Sources

      October 17, 2022
      ChildAssessment.png
    • Approaches to Autism Intervention

      January 31, 2022
      canstockphoto2240982_child-bubbles_thumb.jpg
    • Currently Available Cannabis Products

      September 1, 2022
    • Interpreting Assessment Discrepancies from Multiple Sources

      October 17, 2022
      ChildAssessment.png

    About

    • About Us
    • CME Center
    • FAQ
    • Contact Us

    Shop Online

    • Newsletters
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN Self-Assessment Courses

    Newsletters

    • The Carlat Psychiatry Report
    • The Carlat Child Psychiatry Report
    • The Carlat Addiction Treatment Report
    • The Carlat Hospital Psychiatry Report
    • The Carlat Geriatric Psychiatry Report
    • The Carlat Psychotherapy Report

    Contact

    info@thecarlatreport.com

    866-348-9279

    PO Box 626, Newburyport MA 01950

    Follow Us

    Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

    © 2023 Carlat Publishing, LLC and Affiliates, All Rights Reserved.